|
Nivolumab Injection [Opdivo] Clinical Trials
2 actively recruiting trials
▼ -2 trials since August 2026
Also known as: Nivolumab, carboplatin, paclitaxel
Pipeline
Phase 2: 2
Top Sponsors
- TaiRx, Inc.1
- Inge Marie Svane1
Indications
- Cancer2
- Liver Disease1
- Advanced Cancer1
- Malignant Melanoma1
- Liver Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.